Product Code: PM4660
The global transdermal drug delivery systems market size is expected to reach USD 40.01 billion by 2032, according to a new study by Polaris Market Research. The report "Transdermal Drug Delivery Systems Market Share, Size, Trends, Industry Analysis Report, By Type (Transdermal Patches, Transdermal Semisolids); By Technology; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising healthcare spending and heightened awareness of alternative drug delivery methods are propelling the transdermal drug delivery systems market. With increasing global healthcare expenditures, there's a growing need for cost-effective treatments offering improved patient outcomes. Transdermal drug delivery systems are gaining traction for their advantages over conventional methods. They provide controlled, sustained medication release, enhancing efficacy and minimizing side effects. Non-invasive and painless, transdermal patches offer patient comfort and adherence.
OTC (Over-the-Counter) medications, available without a prescription, are increasingly preferred for self-treating minor ailments. With rising demand for convenient medication options and self-care, the OTC market is witnessing robust growth. Transdermal drug delivery systems offer advantages in the OTC sector, including ease of use and minimal side effects. Consumers can conveniently apply patches at home, aligning with the OTC market's focus on reliable and convenient treatment options. As consumer awareness increases and more products become available, the demand for transdermal drug delivery systems is expected to rise.
The preference for transdermal hormone replacement therapy (HRT) is driving the transdermal drug delivery systems market. Commonly used to alleviate menopausal symptoms, transdermal HRT offers advantages over traditional methods. Transdermal patches deliver hormones directly through the skin, bypassing the digestive system and liver metabolism, resulting in stable hormone levels and reduced side effects. Convenient and easy to use, patches promote patient compliance by eliminating frequent healthcare visits. Discreet and comfortable, they are increasingly popular among patients and healthcare providers.
The transdermal drug delivery systems market is growing due to expanding applications in dermatology and cosmeceuticals. It targets conditions like psoriasis and acne, minimizing systemic side effects. Additionally, transdermal patches are increasingly popular in cosmeceuticals for delivering skincare ingredients such as antioxidants and vitamins. These patches ensure controlled release, providing prolonged skin benefits. Factors like the rising prevalence of skin disorders, increasing consumer awareness about skincare, and demand for non-invasive drug delivery methods are driving the growth of the market.
Transdermal Drug Delivery Systems Market Report Highlights
In 2023, the transdermal patches segment held a significant revenue share owing to ease of use, convenience, and patient compliance.
In 2023, the iontophoresis segment held a significant revenue share owing to efficient drug delivery, enhanced absorption, and growing clinical adoption.
In 2023, the pain management segment held a significant revenue share owing to the growing incidence of chronic pain, targeted delivery, and patient preference.
In 2023, the North America region dominated the global market due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players.
The market is highly competitive owing to the existence of market players with a global presence, including Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, MedPharm Ltd., Novartis International AG, and Purdue Pharma L.P. among others.
Polaris Market Research has segmented the Transdermal Drug Delivery Systems market report based on type, technology, application, and region:
Transdermal Drug Delivery Systems, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Transdermal Patches
- Transdermal Semisolids
Transdermal Drug Delivery Systems, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Iontophoresis
- Electroporation
- Ultrasound
- Mechanical arrays
- Others
Transdermal Drug Delivery Systems, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Pain Management
- Hormonal Applications
- Cardiovascular Diseases
- CNS Disorders
- Others
Transdermal Drug Delivery Systems, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Indonesia
- South Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Transdermal Drug Delivery Systems Market Insights
- 4.1. Transdermal Drug Delivery Systems Market - Application Snapshot
- 4.2. Transdermal Drug Delivery Systems Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising prevalence of chronic diseases is projected to spur the product demand
- 4.2.1.2. Growing Geriatric Population is expected to drive transdermal drug delivery systems market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory and compliance requirements are likely to impede the market growth
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Transdermal Drug Delivery Systems Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Transdermal Drug Delivery Systems Market, by Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 5.3. Iontophoresis
- 5.3.1. Global Transdermal Drug Delivery Systems Market, by Iontophoresis, by Region, 2019-2032 (USD Billion)
- 5.4. Electroporation
- 5.4.1. Global Transdermal Drug Delivery Systems Market, by Electroporation, by Region, 2019-2032 (USD Billion)
- 5.5. Ultrasound
- 5.5.1. Global Transdermal Drug Delivery Systems Market, by Ultrasound, by Region, 2019-2032 (USD Billion)
- 5.6. Mechanical arrays
- 5.6.1. Global Transdermal Drug Delivery Systems Market, by Mechanical arrays, by Region, 2019-2032 (USD Billion)
- 5.7. Others
- 5.7.1. Global Transdermal Drug Delivery Systems Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Transdermal Drug Delivery Systems Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 6.3. Transdermal Patches
- 6.3.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Patches, by Region, 2019-2032 (USD Billion)
- 6.4. Transdermal Semisolids
- 6.4.1. Global Transdermal Drug Delivery Systems Market, by Transdermal Semisolids, by Region, 2019-2032 (USD Billion)
7. Global Transdermal Drug Delivery Systems Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 7.3. Pain Management
- 7.3.1. Global Transdermal Drug Delivery Systems Market, by Pain Management, By Region, 2019-2032 (USD Billion)
- 7.4. Hormonal Applications
- 7.4.1. Global Transdermal Drug Delivery Systems Market, by Hormonal Applications, By Region, 2019-2032 (USD Billion)
- 7.5. Cardiovascular Diseases
- 7.5.1. Global Transdermal Drug Delivery Systems Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Billion)
- 7.6. CNS Disorders
- 7.6.1. Global Transdermal Drug Delivery Systems Market, by CNS Disorders, By Region, 2019-2032 (USD Billion)
- 7.7. Others
- 7.7.1. Global Transdermal Drug Delivery Systems Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Transdermal Drug Delivery Systems Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Transdermal Drug Delivery Systems Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Transdermal Drug Delivery Systems Market - North America
- 8.3.1. North America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.3.2. North America: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.3.3. North America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.3.4. Transdermal Drug Delivery Systems Market - U.S.
- 8.3.4.1. U.S.: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.3.5. Transdermal Drug Delivery Systems Market - Canada
- 8.3.5.1. Canada: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4. Transdermal Drug Delivery Systems Market - Europe
- 8.4.1. Europe: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.3. Europe: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.4. Transdermal Drug Delivery Systems Market - UK
- 8.4.4.1. UK: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.5. Transdermal Drug Delivery Systems Market - France
- 8.4.5.1. France: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.5.3. France: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.6. Transdermal Drug Delivery Systems Market - Germany
- 8.4.6.1. Germany: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.7. Transdermal Drug Delivery Systems Market - Italy
- 8.4.7.1. Italy: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.8. Transdermal Drug Delivery Systems Market - Spain
- 8.4.8.1. Spain: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.9. Transdermal Drug Delivery Systems Market - Netherlands
- 8.4.9.1. Netherlands: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.4.10. Transdermal Drug Delivery Systems Market - Russia
- 8.4.10.1. Russia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5. Transdermal Drug Delivery Systems Market - Asia Pacific
- 8.5.1. Asia Pacific: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.4. Transdermal Drug Delivery Systems Market - China
- 8.5.4.1. China: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.4.3. China: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.5. Transdermal Drug Delivery Systems Market - India
- 8.5.5.1. India: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.5.3. India: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.6. Transdermal Drug Delivery Systems Market - Malaysia
- 8.5.6.1. Malaysia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.7. Transdermal Drug Delivery Systems Market - Japan
- 8.5.7.1. Japan: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.8. Transdermal Drug Delivery Systems Market - Indonesia
- 8.5.8.1. Indonesia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.5.9. Transdermal Drug Delivery Systems Market - South Korea
- 8.5.9.1. South Korea: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6. Transdermal Drug Delivery Systems Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.4. Transdermal Drug Delivery Systems Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.5. Transdermal Drug Delivery Systems Market - UAE
- 8.6.5.1. UAE: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.6. Transdermal Drug Delivery Systems Market - Israel
- 8.6.6.1. Israel: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.6.7. Transdermal Drug Delivery Systems Market - South Africa
- 8.6.7.1. South Africa: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7. Transdermal Drug Delivery Systems Market - Latin America
- 8.7.1. Latin America: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7.4. Transdermal Drug Delivery Systems Market - Mexico
- 8.7.4.1. Mexico: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7.5. Transdermal Drug Delivery Systems Market - Brazil
- 8.7.5.1. Brazil: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
- 8.7.6. Transdermal Drug Delivery Systems Market - Argentina
- 8.7.6.1. Argentina: Transdermal Drug Delivery Systems Market, by Technology, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Transdermal Drug Delivery Systems Market, by Application, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Transdermal Drug Delivery Systems Market, by Type, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. 3M Company
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bayer AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Boehringer Ingelheim International GmbH
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Dr. Reddy's Laboratories Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Endo Pharmaceuticals Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. GlaxoSmithKline plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Hisamitsu Pharmaceutical Co., Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Johnson & Johnson
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. MedPharm Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Mylan N.V.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Novartis International AG
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Noven Pharmaceuticals, Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Purdue Pharma L.P
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Teva Pharmaceutical Industries Ltd.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. UCB S.A.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development